Is Synopsys Stock Your Ticket to Becoming a Millionaire?

29.07.25 02:03 Uhr

Werte in diesem Artikel
Aktien

548,70 EUR 36,90 EUR 7,21%

Indizes

23.308,3 PKT -48,0 PKT -0,21%

21.098,3 PKT -80,3 PKT -0,38%

6.370,9 PKT -18,9 PKT -0,30%

Electronic design automation (EDA) solutions company Synopsys (NASDAQ: SNPS) recently completed its long-awaited acquisition of engineering simulation software company Ansys. The deal was completed shortly after the company received the remaining approval it needed (from China) to make the acquisition. It's an exciting deal that promises to put the new Synopsys ahead of the curve in adopting increasingly complex artificial intelligence (AI)-led product design. That could result in a significant amount of value being generated for shareholders in the future.The company's core activity is EDA, which involves software and hardware that help customers design, verify, and manufacture integrated circuits. As such, its traditional end-market customers are semiconductor and electronics companies. However, that's only part of the story, because the ever-increasing integration of chips into products and their increasing complexity means Synopsys is selling to industries such as defense, automotive, data centers, consumer electronics, healthcare, and industrial companies, among others.The integrated circuits/chips are not just systems designed with a fixed and permanent end in mind; they are constantly interacting with their environment and driven by AI-powered interaction.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

In eigener Sache

Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Synopsys

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Synopsys

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: MotleyFool

Nachrichten zu Synopsys Inc.

Wer­bung

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen